Title
Statements
Body
2025
DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access - January 17, 2025
2024
DEA and HHS Extend Telemedicine Flexibilities through 2025 - November 15, 2024
2023
SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD) - January 18, 2023
2021
Joint Statement of Commitment to Continuing Cooperation on the National Judicial Task Force to Examine State Courts’ Response to Mental Illness - July 16, 2021
Statement on 42 CFR Part 2 Amendments Process - April 9, 2021
Last Updated
Last Updated: 01/20/2025